|
|
|
Insider
Information: |
Carter Bruce L A |
Relationship: |
|
City: |
Seattle |
State: |
WA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
6 |
|
Direct
Shares |
183,977 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$973,941 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
183,977 |
|
|
Total
Value |
$973,941 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-46.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Zymogenetics Inc |
ZGEN |
Director |
2010-10-08 |
115,399 |
2004-06-21 |
0 |
Premium* |
|
Novelion Therapeutics Inc |
NVLN |
Director |
2009-05-14 |
20,000 |
2009-05-14 |
0 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2015-04-13 |
0 |
2015-04-13 |
0 |
Premium* |
|
Xencor Inc |
XNCR |
Director |
2017-06-14 |
48,578 |
2015-06-15 |
0 |
Premium* |
|
Enanta Pharmaceuticals Inc |
ENTA |
Director |
2022-03-21 |
0 |
2019-02-11 |
0 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2019-02-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MRTX |
Mirati Therapeutics, Inc. |
|
|
2019-02-20 |
4 |
OE |
$6.78 |
$20,340 |
D/D |
3,000 |
3,000 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2019-02-20 |
4 |
AS |
$72.50 |
$220,921 |
D/D |
(3,000) |
0 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2019-05-22 |
4 |
AS |
$75.20 |
$225,597 |
D/D |
(3,000) |
0 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2019-05-22 |
4 |
OE |
$6.78 |
$20,340 |
D/D |
3,000 |
3,000 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2019-08-21 |
4 |
AS |
$89.24 |
$267,720 |
D/D |
(3,000) |
0 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2019-08-21 |
4 |
OE |
$6.78 |
$20,340 |
D/D |
3,000 |
3,000 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2019-11-20 |
4 |
AS |
$94.74 |
$284,220 |
D/D |
(3,000) |
0 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2019-11-20 |
4 |
OE |
$6.78 |
$20,340 |
D/D |
3,000 |
3,000 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2020-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
2,000 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2020-05-18 |
4 |
S |
$106.86 |
$427,440 |
D/D |
(4,000) |
2,000 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2020-05-18 |
4 |
OE |
$6.78 |
$27,120 |
D/D |
4,000 |
6,000 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2020-08-11 |
4 |
AS |
$125.78 |
$284,428 |
D/D |
(2,250) |
2,000 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2020-08-11 |
4 |
OE |
$6.78 |
$15,255 |
D/D |
2,250 |
4,250 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2020-12-14 |
4 |
AS |
$240.93 |
$554,127 |
D/D |
(2,250) |
2,000 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2020-12-14 |
4 |
OE |
$6.78 |
$15,255 |
D/D |
2,250 |
4,250 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
1,475 |
3,475 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2021-02-02 |
4 |
AS |
$190.50 |
$430,018 |
D/D |
(2,250) |
3,475 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2021-02-02 |
4 |
OE |
$6.78 |
$15,255 |
D/D |
2,250 |
5,725 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
2,546 |
6,021 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2022-08-12 |
4 |
S |
$85.04 |
$854,899 |
D/D |
(10,000) |
6,021 |
0 |
% |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2022-08-12 |
4 |
OE |
$27.00 |
$270,000 |
D/D |
10,000 |
16,021 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2023-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
4,444 |
10,465 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
|
|
2024-01-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(17,273) |
0 |
0 |
- |
|
ZGEN |
Zymogenetics Inc |
CEO & Chairman of the Board |
|
2007-08-03 |
4 |
B |
$12.56 |
$197,847 |
D/D |
15,750 |
147,049 |
2.81 |
- |
|
ZGEN |
Zymogenetics Inc |
CEO & Chairman of the Board |
|
2008-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
100 |
147,149 |
0 |
- |
|
61 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|